459 filings
Page 2 of 23
8-K
4xdv fkef
12 May 20
Phio Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
4:36pm
D
rhtyx6fe9j
14 Apr 20
$4.38M in options / securities to be acquired, sold $4.38M, 10 investors
5:16pm
SC 13G
357 nw7k8ym1tm
9 Apr 20
Phio Pharmaceuticals / CVI Investments ownership change
10:13am
SC 13G
bm0a58sr1o6l4p
8 Apr 20
Phio Pharmaceuticals / ARMISTICE CAPITAL ownership change
4:42pm
8-K
pfq05 i2orl9
2 Apr 20
Entry into a Material Definitive Agreement
5:00pm
424B5
o5bw43i
1 Apr 20
Prospectus supplement for primary offering
5:01pm
8-K
0qdmwfz tbyo8di
26 Mar 20
Phio Pharmaceuticals Reports Year End 2019 Financial Results and Provides Business Update
5:26pm
8-K
2tsmr8t9
12 Mar 20
Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene
4:15pm
4
wtm79tqa
3 Mar 20
Phio Pharmaceuticals / Gerrit Dispersyn ownership change
8:27pm
S-8
gn48yiqe z67z
28 Feb 20
Registration of securities for employees
12:00am
D
zgh1g9con6ukd
24 Feb 20
$1.9M in options / securities to be acquired, sold $1.9M, 6 investors
5:27pm
SC 13G
l3kgp jrgb975u
14 Feb 20
Beneficial ownership report
2:49pm
8-K
brzr3yb
13 Feb 20
Phio Pharmaceuticals Announces Pricing of $8.0 Million
5:25pm
SC 13G
6b42 v95j
13 Feb 20
Phio Pharmaceuticals Corp.
5:23pm
424B4
602lv4
12 Feb 20
Prospectus supplement with pricing info
5:21pm
EFFECT
nug2rvepi aq
12 Feb 20
Notice of effectiveness
12:15am
SC 13G
a58xk zv8
11 Feb 20
Phio Pharmaceuticals Corp.
1:04pm